These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 28827223)
1. Long Noncoding RNA Facilitated Gene Therapy Reduces Atherosclerosis in a Murine Model of Familial Hypercholesterolemia. Tontonoz P; Wu X; Jones M; Zhang Z; Salisbury D; Sallam T Circulation; 2017 Aug; 136(8):776-778. PubMed ID: 28827223 [No Abstract] [Full Text] [Related]
3. microRNA-185 modulates low density lipoprotein receptor expression as a key posttranscriptional regulator. Jiang H; Zhang J; Du Y; Jia X; Yang F; Si S; Wang L; Hong B Atherosclerosis; 2015 Dec; 243(2):523-32. PubMed ID: 26523989 [TBL] [Abstract][Full Text] [Related]
5. Therapeutic silencing of FSP27 reduces the progression of atherosclerosis in Ldlr Rajamoorthi A; Lee RG; Baldán Á Atherosclerosis; 2018 Aug; 275():43-49. PubMed ID: 29859472 [TBL] [Abstract][Full Text] [Related]
6. A novel small molecule liver X receptor transcriptional regulator, nagilactone B, suppresses atherosclerosis in apoE-deficient mice. Gui Y; Yao S; Yan H; Hu L; Yu C; Gao F; Xi C; Li H; Ye Y; Wang Y Cardiovasc Res; 2016 Oct; 112(1):502-14. PubMed ID: 27460841 [TBL] [Abstract][Full Text] [Related]
7. Adoptive transfer of CX3CR1 transduced-T regulatory cells improves homing to the atherosclerotic plaques and dampens atherosclerosis progression. Bonacina F; Martini E; Svecla M; Nour J; Cremonesi M; Beretta G; Moregola A; Pellegatta F; Zampoleri V; Catapano AL; Kallikourdis M; Norata GD Cardiovasc Res; 2021 Jul; 117(9):2069-2082. PubMed ID: 32931583 [TBL] [Abstract][Full Text] [Related]
12. Haloperidol inhibits the development of atherosclerotic lesions in LDL receptor knockout mice. van der Sluis RJ; Nahon JE; Reuwer AQ; Van Eck M; Hoekstra M Br J Pharmacol; 2015 May; 172(9):2397-405. PubMed ID: 25572138 [TBL] [Abstract][Full Text] [Related]
13. Sleeping Beauty Transposon Vectors in Liver-directed Gene Delivery of LDLR and VLDLR for Gene Therapy of Familial Hypercholesterolemia. Turunen TA; Kurkipuro J; Heikura T; Vuorio T; Hytönen E; Izsvák Z; Ylä-Herttuala S Mol Ther; 2016 Mar; 24(3):620-35. PubMed ID: 26670130 [TBL] [Abstract][Full Text] [Related]
14. TUG1 knockdown ameliorates atherosclerosis via up-regulating the expression of miR-133a target gene FGF1. Zhang L; Cheng H; Yue Y; Li S; Zhang D; He R Cardiovasc Pathol; 2018; 33():6-15. PubMed ID: 29268138 [TBL] [Abstract][Full Text] [Related]
15. Perinatal Hypercholesterolemia Exacerbates Atherosclerosis Lesions in Offspring by Altering Metabolism of Trimethylamine-N-Oxide and Bile Acids. Trenteseaux C; Gaston AT; Aguesse A; Poupeau G; de Coppet P; Andriantsitohaina R; Laschet J; Amarger V; Krempf M; Nobecourt-Dupuy E; Ouguerram K Arterioscler Thromb Vasc Biol; 2017 Nov; 37(11):2053-2063. PubMed ID: 28935756 [TBL] [Abstract][Full Text] [Related]
16. Improving lipoprotein profiles by liver-directed gene transfer of low density lipoprotein receptor gene in hypercholesterolaemia mice. Ou H; Zhang Q; Zeng J J Genet; 2016 Jun; 95(2):311-6. PubMed ID: 27350674 [TBL] [Abstract][Full Text] [Related]
17. Nuclear factor E2-related factor 2 deficiency impairs atherosclerotic lesion development but promotes features of plaque instability in hypercholesterolaemic mice. Ruotsalainen AK; Lappalainen JP; Heiskanen E; Merentie M; Sihvola V; Näpänkangas J; Lottonen-Raikaslehto L; Kansanen E; Adinolfi S; Kaarniranta K; Ylä-Herttuala S; Jauhiainen M; Pirinen E; Levonen AL Cardiovasc Res; 2019 Jan; 115(1):243-254. PubMed ID: 29917052 [TBL] [Abstract][Full Text] [Related]
18. MicroRNA 302a is a novel modulator of cholesterol homeostasis and atherosclerosis. Meiler S; Baumer Y; Toulmin E; Seng K; Boisvert WA Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):323-31. PubMed ID: 25524771 [TBL] [Abstract][Full Text] [Related]
19. Exosome-based Li Z; Zhao P; Zhang Y; Wang J; Wang C; Liu Y; Yang G; Yuan L Theranostics; 2021; 11(6):2953-2965. PubMed ID: 33456582 [TBL] [Abstract][Full Text] [Related]
20. CalDAG-GEFI Deficiency Reduces Atherosclerotic Lesion Development in Mice. Boulaftali Y; Owens AP; Beale A; Piatt R; Casari C; Lee RH; Conley PB; Paul DS; Mackman N; Bergmeier W Arterioscler Thromb Vasc Biol; 2016 May; 36(5):792-9. PubMed ID: 26988592 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]